We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LAES:NASDAQSEALSQ Corp Analysis

Data as of 2026-08-23 - not real-time

$2.54

Latest Price

9/10Risk

Risk Level: High

Executive Summary

SEALSQ Corp is priced at $2.54 and its moving averages line up in bearish order, the shorter trailing the longer. Across the trailing 30 sessions it lost 9.3%. RSI sits at 45.3, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near $2.22 and resistance around $3.07.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 131.3% above the current price. Revenue is growing at 118.2% on a -187.3% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 63.0%, a beta of 3.39 and a maximum drawdown of 72.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

Benzinga.com4monSEALSQ Earnings & ForecastsSEALSQ LAES last issued guidance on July 6, 2026 for fiscal year 2026. The...Geneva, Switzerland , Aug. 07, 2026 GLOBE NEWSWIRE -- August 7, 2026 — SEALSQ Corp NASDAQ: LAES 'SEALSQ' or the...Geneva, Switzerland, July 29, 2026 GLOBE NEWSWIRE -- SEALSQ Corp NASDAQ: LAES 'SEALSQ' or 'Company' , a company that...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 3.52
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 3.52
  • Analyst targets imply +131.3% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Negative profit margin of -187.3%
  • Analyst targets imply +131.3% versus the current price
  • Negative return on equity of -12.7%

Key Metrics & Analysis

Financial Health

Revenue Growth118.20%
Profit Margin-187.34%
P/E Ratio-12.1
ROE-12.71%
ROA-8.27%
Debt/Equity1.73
P/B Ratio1.1
Op. Cash Flow$-31257000
Free Cash Flow$-10687875
Industry P/E35.2

Technical Analysis

TrendBearish
RSI45.3
Support$2.22
Resistance$3.07
MA 20$2.56
MA 50$2.77
MA 200$3.52
MACDBullish
VolumeDecreasing
Fear & Greed Index94.41

Valuation

Target Price$5.88
Upside/Downside131.30%
GradeFair
TypeBlend

Risk Assessment

Beta3.39
Volatility63.02%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.